- About Synapse
- How to Participate
- KAMJE Databases
- About Synapse
- How to Participate
- KAMJE Databases
- Home
- Journal List
- Cancer Res Treat
28 results
| 293 |
The Era of Antibody Drug Conjugates in Lung Cancer: Trick or Threat?
Mariona Riudavets, David Planchard
KMSID: 1516090316 Cancer Res Treat. 2025;57(2):293-311. Published online 2024 November 28 DOI: http://dx.doi.org/10.4143/crt.2024.714   | |
| 312 |
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2022
Eun Hye Park, Kyu-Won Jung, Nam Ju Park, Mee Joo Kang, E Hwa Yun, Hye-Jin Kim, Jeong-Eun Kim, Hyun-Joo Kong, Kui-Son Choi, Han-Kwang Yang
KMSID: 1516090320 Cancer Res Treat. 2025;57(2):312-330. Published online 2025 March 11 DOI: http://dx.doi.org/10.4143/crt.2025.264  | |
| 331 |
Prediction of Cancer Incidence and Mortality in Korea, 2025
Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Jeong-Eun Kim, Hyun-Joo Kong, Kui Son Choi, Han-Kwang Yang
KMSID: 1516090318 Cancer Res Treat. 2025;57(2):331-338. Published online 2025 March 11 DOI: http://dx.doi.org/10.4143/crt.2025.263 | |
| 339 |
Weight Change after Cancer Diagnosis and Risk of Diabetes Mellitus: A Population-Based Nationwide Study
Hye Yeon Koo, Kyungdo Han, Mi Hee Cho, Wonyoung Jung, Jinhyung Jung, In Young Cho, Dong Wook Shin
KMSID: 1516090301 Cancer Res Treat. 2025;57(2):339-349. Published online 2024 August 29 DOI: http://dx.doi.org/10.4143/crt.2024.586 | |
| 350 |
Target-Enhanced Whole-Genome Sequencing Shows Clinical Validity Equivalent to Commercially Available Targeted Oncology Panel
Sangmoon Lee, Jin Roh, Jun Sung Park, Islam Oguz Tuncay, Wonchul Lee, Jung-Ah Kim, Brian Baek-Lok Oh, Jong-Yeon Shin, Jeong Seok Lee, Young Seok Ju, Ryul Kim, Seongyeol Park, Jaemo Koo, Hansol Park, Joonoh Lim, Erin Connolly-Strong, Tae-Hwan Kim, Yong Won Choi, Mi Sun Ahn, Hyun Woo Lee, Seokhwi Kim, Jang-Hee Kim, Minsuk Kwon
KMSID: 1516090294 Cancer Res Treat. 2025;57(2):350-361. Published online 2024 September 19 DOI: http://dx.doi.org/10.4143/crt.2024.114 | |
| 362 |
Association between Tumor Size at the Time of Disease Progression and Survival Outcomes
Chi Hoon Maeng, Bum Jun Kim, Myung-Ju Ahn, In Sil Choi, Dae Young Zang, Bo-Hyung Kim, Minji Kwon, Dae Seog Heo, Bhumsuk Keam
KMSID: 1516090313 Cancer Res Treat. 2025;57(2):362-368. Published online 2024 October 22 DOI: http://dx.doi.org/10.4143/crt.2024.690 | |
| 369 |
Association between Levetiracetam Use and Survival in Patients with Glioblastoma: A Nationwide Population-Based Study
Yeonhu Lee, Eunyoung Lee, Tae Hoon Roh, Se-Hyuk Kim
KMSID: 1516090293 Cancer Res Treat. 2025;57(2):369-377. Published online 2024 September 6 DOI: http://dx.doi.org/10.4143/crt.2024.355 | |
| 378 |
Choosing Wisely between Radiotherapy Dose-Fractionation Schedules: The Molecular Graded Prognostic Assessment for Elderly Glioblastoma Patients
Hye In Lee, Jina Kim, In Ah Kim, Joo Ho Lee, Jaeho Cho, Rifaquat Rahman, Geoffrey Fell, Chan Woo Wee, Hong In Yoon
KMSID: 1516090311 Cancer Res Treat. 2025;57(2):378-386. Published online 2024 September 11 DOI: http://dx.doi.org/10.4143/crt.2024.680 | |
| 387 |
Association of Shorter Time to Recurrence and Recurrence-Free Survival with Transthoracic Lung Biopsy in Stage I Lung Cancer
Kum Ju Chae, Hyunsook Hong, Hyungin Park, Soon Ho Yoon
KMSID: 1516090304 Cancer Res Treat. 2025;57(2):387-400. Published online 2024 September 2 DOI: http://dx.doi.org/10.4143/crt.2024.560 | |
| 401 |
Histological Assessment and Interobserver Agreement in Major Pathologic Response for Non–Small Cell Lung Cancer with Neoadjuvant Therapy
Sungjin Kim, Jeonghyo Lee, Jin-Haeng Chung
KMSID: 1516090309 Cancer Res Treat. 2025;57(2):401-411. Published online 2024 September 9 DOI: http://dx.doi.org/10.4143/crt.2024.670 | |
| 412 |
Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non–Small Cell Lung Cancer with PD-L1 Expression Levels of 1% to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective Study
Naoya Nishioka, Tae Hata, Tadaaki Yamada, Yasuhiro Goto, Akihiko Amano, Yoshiki Negi, Satoshi Watanabe, Naoki Furuya, Tomohiro Oba, Tatsuki Ikoma, Akira Nakao, Keiko Tanimura, Hirokazu Taniguchi, Akihiro Yoshimura, Tomoya Fukui, Daiki Murata, Kyoichi Kaira, Shinsuke Shiotsu, Makoto Hibino, Asuka Okada, Yusuke Chihara, Hayato Kawachi, Takashi Kijima, Koichi Takayama
KMSID: 1516090315 Cancer Res Treat. 2025;57(2):412-421. Published online 2024 October 25 DOI: http://dx.doi.org/10.4143/crt.2024.748 | |
| 422 |
Unraveling the Impact of Sarcopenia-Induced Lymphopenia on Treatment Response and Prognosis in Patients with Stage III Non–Small Cell Lung Cancer: Insights for Optimizing Chemoradiation and Immune Checkpoint Inhibitor
Joongyo Lee, Kyung Hwan Kim, Jina Kim, Chang Geol Lee, Jaeho Cho, Hong In Yoon, Yeona Cho
KMSID: 1516090300 Cancer Res Treat. 2025;57(2):422-433. Published online 2024 October 30 DOI: http://dx.doi.org/10.4143/crt.2024.493 | |
| 434 |
Combination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer after Trastuzumab Failure (PROVE): A Prospective Phase 2 Study
Chunfang Hao, Xu Wang, Yehui Shi, Zhongsheng Tong, Shufen Li, Xiaodong Liu, Lan Zhang, Jie Zhang, Wenjing Meng, Li Zhang
KMSID: 1516090298 Cancer Res Treat. 2025;57(2):434-442. Published online 2024 August 9 DOI: http://dx.doi.org/10.4143/crt.2024.340 | |
| 443 |
Harnessing Institutionally Developed Clinical Targeted Sequencing to Improve Patient Survival in Breast Cancer: A Seven-Year Experience
Jiwon Koh, Jinyong Kim, Go-Un Woo, Hanbaek Yi, So Yean Kwon, Jeongmin Seo, Jeong Mo Bae, Jung Ho Kim, Jae Kyung Won, Han Suk Ryu, Yoon Kyung Jeon, Dae-Won Lee, Miso Kim, Tae-Yong Kim, Kyung-Hun Lee, Tae-You Kim, Jee-Soo Lee, Moon-Woo Seong, Sheehyun Kim, Sungyoung Lee, Hongseok Yun, Myung Geun Song, Jaeyong Choi, Jong-Il Kim, Seock-Ah Im
KMSID: 1516090296 Cancer Res Treat. 2025;57(2):443-456. Published online 2024 August 21 DOI: http://dx.doi.org/10.4143/crt.2024.296 | |
| 457 |
Synergistic Activation of LEPR and ADRB2 Induced by Leptin Enhances Reactive Oxygen Specie Generation in Triple-Negative Breast Cancer Cells
Chang Liu, Jing Yu, Yongjun Du, Yu Xie, Xiaofei Song, Chang Liu, Yan Yan, Yue Wang, Junfang Qin
KMSID: 1516090297 Cancer Res Treat. 2025;57(2):457-477. Published online 2024 August 21 DOI: http://dx.doi.org/10.4143/crt.2024.368 | |
| 478 |
Kinect-Based Mixed Reality Exercise Program Improves Physical Function and Quality of Life in Breast Cancer Survivors: A Randomized Clinical Trial
Byunggul Lim, Xinxing Li, Yunho Sung, Parivash Jamrasi, SoYoung Ahn, Hyejung Shin, Wook Song
KMSID: 1516090317 Cancer Res Treat. 2025;57(2):478-491. Published online 2024 October 30 DOI: http://dx.doi.org/10.4143/crt.2024.758 | |
| 492 |
Presence of RB1 or Absence of LRP1B Mutation Predicts Poor Overall Survival in Patients with Gastric Neuroendocrine Carcinoma and Mixed Adenoneuroendocrine Carcinoma
In Hye Song, Bokyung Ahn, Young Soo Park, Deok Hoon Kim, Seung-Mo Hong
KMSID: 1516090308 Cancer Res Treat. 2025;57(2):492-506. Published online 2024 September 27 DOI: http://dx.doi.org/10.4143/crt.2024.667 | |
| 507 |
Is Colonoscopy Alone Adequate for Surveillance in Stage I Colorectal Cancer?
Seijong Kim, Jung Kyong Shin, Yoonah Park, Jung Wook Huh, Hee Cheol Kim, Seong Hyeon Yun, Woo Yong Lee, Yong Beom Cho
KMSID: 1516090302 Cancer Res Treat. 2025;57(2):507-518. Published online 2024 October 4 DOI: http://dx.doi.org/10.4143/crt.2024.526 | |
| 519 |
Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-analysis Based on Individual Patient-Level Data of Randomized Trials
Jaewon Hyung, Minsu Kang, Ilhwan Kim, Kyu-pyo Kim, Baek-Yeol Ryoo, Jaekyung Cheon, Hyewon Ryu, Ji Sung Lee, Ji-Won Kim, In Sil Choi, Jin Hyun Park, Ghassan K. Abou-Alfa, Jin Won Kim, Changhoon Yoo
KMSID: 1516090305 Cancer Res Treat. 2025;57(2):519-527. Published online 2024 October 17 DOI: http://dx.doi.org/10.4143/crt.2024.652 | |
| 528 |
Stage Evaluation of Cystic Duct Cancer
Yeseul Kim, You-Na Sung, Haesung Jung, Kyung Jin Lee, Daegwang Yoo, Sun-Young Jun, HyungJun Cho, Shin Hwang, Woohyung Lee, Seung-Mo Hong
KMSID: 1516090306 Cancer Res Treat. 2025;57(2):528-538. Published online 2024 September 19 DOI: http://dx.doi.org/10.4143/crt.2024.660 | |
| 539 |
Determinants of Prostate Cancer Screening in Korean Men: A Nationwide Study Using the Korean National Cancer Screening Survey 2023
Giap Viet Nguyen, Kyeongmin Lee, Hyeon Ji Lee, EunKyo Kang, Mina Suh, Jae Kwan Jun, Kui Son Choi
KMSID: 1516090319 Cancer Res Treat. 2025;57(2):539-546. Published online 2024 October 29 DOI: http://dx.doi.org/10.4143/crt.2024.879 | |
| 547 |
Application of Machine Learning Algorithms for Risk Stratification and Efficacy Evaluation in Cervical Cancer Screening among the ASCUS/LSIL Population: Evidence from the Korean HPV Cohort Study
Heekyoung Song, Hong Yeon Lee, Shin Ah Oh, Jaehyun Seong, Soo Young Hur, Youn Jin Choi
KMSID: 1516090299 Cancer Res Treat. 2025;57(2):547-557. Published online 2024 September 6 DOI: http://dx.doi.org/10.4143/crt.2024.465 | |
| 558 |
Survival of Children with Acute Lymphoblastic Leukemia with Risk Group–Based Protocol Changes: A Single-Center Experience with 460 Patients over a 20-Year Period
Na Hee Lee, Hee Young Ju, Eun Sang Yi, Young Bae Choi, Keon Hee Yoo, Hong Hoe Koo
KMSID: 1516090295 Cancer Res Treat. 2025;57(2):558-569. Published online 2024 September 27 DOI: http://dx.doi.org/10.4143/crt.2024.127 | |
| 570 |
Long-term Clinical Efficacy of Radiotherapy for Patients with Stage I-II Gastric Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A Retrospective Multi-institutional Study
Jae Uk Jeong, Hyo Chun Lee, Jin Ho Song, Keun Yong Eom, Jin Hee Kim, Yoo Kang Kwak, Woo Chul Kim, Sun Young Lee, Jin Hwa Choi, Kang Kyu Lee, Jong Hoon Lee
KMSID: 1516090307 Cancer Res Treat. 2025;57(2):570-579. Published online 2024 October 4 DOI: http://dx.doi.org/10.4143/crt.2024.651 | |
| 580 |
Higher Microbial Abundance and Diversity in Bronchus-Associated Lymphoid Tissue Lymphomas Than in Non-cancerous Lung Tissues
Jung Heon Kim, Jae Sik Kim, Noorie Choi, Jiwon Koh, Yoon Kyung Jeon, Ji Hyun Chang, Eung Soo Hwang, Il Han Kim
KMSID: 1516090312 Cancer Res Treat. 2025;57(2):580-589. Published online 2024 September 30 DOI: http://dx.doi.org/10.4143/crt.2024.689 | |
| 590 |
Nivolumab in Relapsed or Refractory Primary Central Nervous System Lymphoma: Multicenter, Retrospective Study
Jun Ho Yi, Seok Jin Kim, Sang-A Kim, Jongheon Jung, Dok Hyun Yoon
KMSID: 1516090303 Cancer Res Treat. 2025;57(2):590-596. Published online 2024 August 16 DOI: http://dx.doi.org/10.4143/crt.2024.531 | |
| 597 |
Clinical Impact of Microbiome Characteristics in Treatment-Naïve Extranodal NK/T-Cell Lymphoma Patients
Sang Eun Yoon, Woorim Kang, Junhun Cho, Mauricio Chalita, Je Hee Lee, Dong-Wook Hyun, Hyun Kim, Seok Jin Kim, Won Seog Kim
KMSID: 1516090310 Cancer Res Treat. 2025;57(2):597-611. Published online 2024 August 16 DOI: http://dx.doi.org/10.4143/crt.2024.675 | |
| 612 |
The Role of Direct Oral Anticoagulants in Managing Myeloproliferative Neoplasms Patients
Ji Yun Lee, Ju-Hyun Lee, Woochan Park, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Sang-A Kim, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang
KMSID: 1516090314 Cancer Res Treat. 2025;57(2):612-620. Published online 2024 September 20 DOI: http://dx.doi.org/10.4143/crt.2024.738 | |